The price set by the US pharmaceutical company is above the $ 19.50 (16.5 euros) that he advanced Pfizer for the vaccine that develops together with the German BioNTech and which is, as in the case of Moderna, at the beginning of phase 3. It is also immensely higher than the cost it has set AstraZeneca, which collaborates with the Oxford University, for Germany, Italy, France and the Netherlands: between 3 and 4 dollars (2.5 and 3.4 euros) per dose.

Region:

World

Category:

Technology